Videos

The MINI Act would allow more time for research, investment and infrastructure in the development of novel therapies like genetically targeted technologies for heart patients.

Listen to Robert Popovian, PharmD, Anne Sydor, PhD, and Ryan Gough as they discuss the impact of the Inflation Reduction Act’s maximum fair price on patients.

Angie Peterson was diagnosed with FH. Her doctor recommended one treatment – but her insurance forced her on another.

People with hypertension need options, support and access to the treatment that works best for them.

Patients living with cardiovascular conditions need tailored, quality care. That’s where specialty pharmacies come in.

Listen to Michael Gibson, MS, MD, Chris Kelly and Ryan Gough as they discuss the need for ongoing innovation and how policy can encourage breakthrough treatments like genetically targeted technologies.

Innovation promises new ways to deliver medication. One example is genetically targeted technologies.

As rates of heart attack and stroke soar, now is the time for policymakers to ensure that heart patients get the right medicine at the right time.

Alternative funding programs come at a significant cost to patients and the health care system.

Darin Burnham had a heart attack and was denied his doctor-prescribed medication to manage his condition. Hear his story.

Latrice Baxter went in for routine heart screens and several hours later found herself on the operating table. Hear her story.